“The compound SR-17018 is the initial biased agonist in the mu opioid receptor that does not bring about tolerance with Persistent use,” says Stahl, a senior staff scientist in the Bohn lab. “This is the fascinating characteristic for prospective use within the context of Serious, critical ache.” – Contrary to most opioids, SR-1701